Insider Buying: Vapotherm Inc (NYSE:VAPO) Director Purchases $173,600.00 in Stock
Vapotherm Inc (NYSE:VAPO) Director Anthony L. Arnerich bought 20,000 shares of the business’s stock in a transaction dated Wednesday, September 11th. The stock was bought at an average cost of $8.68 per share, for a total transaction of $173,600.00.
NYSE VAPO opened at $9.80 on Thursday. Vapotherm Inc has a 12 month low of $8.30 and a 12 month high of $24.63. The stock has a market cap of $158.54 million and a P/E ratio of -0.71. The stock’s fifty day moving average price is $12.60 and its 200-day moving average price is $17.46. The company has a current ratio of 5.22, a quick ratio of 4.34 and a debt-to-equity ratio of 1.42.
Vapotherm (NYSE:VAPO) last released its earnings results on Monday, July 29th. The company reported ($0.76) EPS for the quarter, topping analysts’ consensus estimates of ($0.81) by $0.05. The company had revenue of $11.99 million during the quarter, compared to analysts’ expectations of $11.90 million. As a group, analysts forecast that Vapotherm Inc will post -3.07 earnings per share for the current fiscal year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Perceptive Advisors LLC grew its stake in shares of Vapotherm by 12.7% in the second quarter. Perceptive Advisors LLC now owns 1,404,470 shares of the company’s stock worth $32,302,000 after acquiring an additional 158,155 shares during the last quarter. First Light Asset Management LLC lifted its holdings in shares of Vapotherm by 24.6% during the second quarter. First Light Asset Management LLC now owns 496,969 shares of the company’s stock valued at $11,430,000 after purchasing an additional 97,977 shares in the last quarter. Federated Investors Inc. PA lifted its holdings in shares of Vapotherm by 32.8% during the first quarter. Federated Investors Inc. PA now owns 398,435 shares of the company’s stock valued at $7,829,000 after purchasing an additional 98,435 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Vapotherm by 60.2% during the second quarter. Vanguard Group Inc. now owns 376,660 shares of the company’s stock valued at $8,663,000 after purchasing an additional 141,539 shares in the last quarter. Finally, BlackRock Inc. lifted its holdings in shares of Vapotherm by 24.7% during the second quarter. BlackRock Inc. now owns 292,171 shares of the company’s stock valued at $6,719,000 after purchasing an additional 57,950 shares in the last quarter. 50.85% of the stock is currently owned by hedge funds and other institutional investors.
Vapotherm Company Profile
Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.
Further Reading: What is the return on assets (ROA) ratio?
Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.